Just two months after telegraphing plans to lay off 641 staffers at two of its Massachusetts sites, Takeda is parting ways ...

Under federal law, former FDA employees are prohibited from engaging in certain lobbying activities—but an investigation ...

The world’s first injectable immune checkpoint inhibitor likely won’t make it to the U.S. anytime soon after the ...

After more than a decade with no treatment advances for chronic obstructive pulmonary disease (COPD), two have been approved ...

In an unconventional move, Novartis recently said it will propose Giovanni Caforio, M.D., who recently stepped down as ...

In a major win for Johnson & Johnson and Legend Biotech, their star CAR-T therapy Carvykti showed it can prolong the lives of ...

With four contract modifications totaling more than $250 million, the government is leveling up its agreements with long-time ...

Inovio has changed its chief commercial officer ahead of the planned launch of its first DNA medicine, putting Merck veteran ...

As the November U.S. elections near, it's clear that drug pricing will remain an important topic for voters and politicians.

In yet another legal development surrounding counterfeit HIV drugs, a Florida court has handed down an indictment for the ...

For its latest celebrity partnership, Pfizer went in a “Fabulous” direction. | For its latest celebrity partnership, Pfizer ...

Which companies do Americans associate most with weight loss medication? If you answered Eli Lilly or Novo Nordisk, think ...